naltrexone has been researched along with Hyperandrogenism in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böttcher, B; Dörr, HG; Wildt, L | 1 |
| Hadziomerović, D; Rabenbauer, B; Wildt, L | 1 |
| Alba, F; Candía, M; Castillo, T; Cipriano, A; Devoto, L; López, G; Sir, T | 1 |
| Caruso, A; De Marinis, L; Fulghesu, AM; Lanzone, A; Mancini, A; Pavone, V; Valle, D; Villa, P | 1 |
| Calvillán, M; Castillo, T; López, G; Rabenbauer, B; Sir-Petermann, T; Wildt, L | 1 |
3 trial(s) available for naltrexone and Hyperandrogenism
| Article | Year |
|---|---|
Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women.
Topics: Adult; Androgens; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2006 |
Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.
Topics: Adult; Female; Glucose Tolerance Test; Growth Hormone-Releasing Hormone; Hormones; Human Growth Hormone; Humans; Hyperandrogenism; Insulin; Insulin Secretion; Naltrexone; Narcotic Antagonists; Obesity; Polycystic Ovary Syndrome; Reference Values; Time Factors | 1997 |
Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Dehydroepiandrosterone Sulfate; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Insulin Secretion; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Naltrexone; Narcotic Antagonists; Opioid Peptides; Placebos; Testosterone | 1998 |
2 other study(ies) available for naltrexone and Hyperandrogenism
| Article | Year |
|---|---|
Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH).
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Female; Humans; Hyperandrogenism; Hypothalamic Diseases; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Primary Ovarian Insufficiency; Young Adult | 2014 |
[Effect of chronic blockade of the opiodergic receptor on insulin resistance in a hyperandrogenic woman].
Topics: Acanthosis Nigricans; Administration, Oral; Adult; Blood Glucose; Female; Gonadotropins; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Naltrexone; Testosterone; Time Factors | 1994 |